uniQure N.V.
QURECIK 0001590560 · last filing Jul 7, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
52,249 bought / 72,249 sold
net −20,000 sh · −$2.37M
- buys
- 4
- sells
- 7
- insiders active
- 3
Filing tape
Filed Tue, Jul 7, 2026
- −0 sh · $543.3K
Kapusta Matthew C — CEO, Managing Director · Director
- Exercised21,082Ordinary Shares@ $19.39→ 540,309 held
- Sold9,200Ordinary Shares@ $44.43→ 531,109 held
- Sold4,282Ordinary Shares@ $45.43→ 526,827 held
- Sold7,600Ordinary Shares@ $45.89→ 519,227 held
- Exercised21,082Stock Option (Right to Buy)→ 0 held
Filed Thu, Jul 2, 2026
- −20,000 sh · $1.34M
Abi-Saab Walid — Chief Medical Officer
- Exercised10,000Ordinary Shares@ $5.59→ 178,235 held
- Sold10,000Ordinary Shares@ $46.46→ 168,235 held
- Sold20,000Ordinary Shares@ $46.40→ 148,235 held
- Exercised10,000Stock Option (Right to Buy)→ 50,500 held
- −0 sh · $486.8K
Kaye Jack — Director
- Exercised4,107Ordinary Shares@ $37.00→ 30,103 held
- Sold4,107Ordinary Shares@ $46.49→ 25,996 held
- Exercised17,060Ordinary Shares@ $20.18→ 43,056 held
- Sold17,060Ordinary Shares@ $46.43→ 25,996 held
- Exercised4,107Stock Option (Right to Buy)→ 0 held
- Exercised17,060Stock Option (Right to Buy)→ 0 held
Insiders on this tape
- Kapusta Matthew CCEO, Managing Director · Director
- Abi-Saab WalidChief Medical Officer
- Kaye JackDirector
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.